Global Gastroparesis Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	166 Pages	TechNavio	October, 2023	INF18310344

Best Price Guarantee
Price	from $2,500
Length	166 Pages
Publisher	TechNavio
Published Date	October, 2023
SKU	INF18310344

Global Gastroparesis Drugs Market 2024-2028

The gastroparesis drugs market is forecasted to grow by USD 1,421.42 mn during 2023-2028, accelerating at a CAGR of 3.69% during the forecast period. The report on the gastroparesis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of diabetes, increasing prevalence of gastroparesis, and increasing awareness about gastroparesis.

Technavio's gastroparesis drugs market is segmented as below:

By Drug Class

Prokinetic agents
Antiemetics
Botulinum toxin injection

By Disease Type

Idiopathic gastroparesis
Diabetic gastroparesis
Post-surgical gastroparesis

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing growth opportunities in emerging markets as one of the prime reasons driving the gastroparesis drugs market growth during the next few years. Also, increasing number of clinical research and rising funding in healthcare industry will lead to sizable demand in the market.

The report on the gastroparesis drugs market covers the following areas:

Gastroparesis drugs market sizing
Gastroparesis drugs market forecast
Gastroparesis drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastroparesis drugs market vendors that include Abbott Laboratories, AbbVie Inc., Aclipse Therapeutics, ANI Pharmaceuticals Inc., Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Eisai Co. Ltd., Evoke Pharma Inc., GlaxoSmithKline Plc, Ipca Laboratories Ltd., Johnson and Johnson, Medtronic Plc, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Processa Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., Theravance Biopharma Inc., Vanda Pharmaceuticals Inc., and Neurogastrx Inc.. Also, the gastroparesis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market by Geography; Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class; Exhibit 06: Executive Summary - Chart on Market Segmentation by Disease Type; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global gastroparesis drugs market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global gastroparesis drugs market 2018 - 2022 ($ million); 4.2 Drug Class Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million); 4.3 Disease Type Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Drug Class: 6.1 Market segments; Exhibit 30: Chart on Drug Class - Market share 2023-2028 (%); Exhibit 31: Data Table on Drug Class - Market share 2023-2028 (%); 6.2 Comparison by Drug Class; Exhibit 32: Chart on Comparison by Drug Class; Exhibit 33: Data Table on Comparison by Drug Class; 6.3 Prokinetic agents - Market size and forecast 2023-2028; Exhibit 34: Chart on Prokinetic agents - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Prokinetic agents - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Prokinetic agents - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Prokinetic agents - Year-over-year growth 2023-2028 (%); 6.4 Antiemetics - Market size and forecast 2023-2028; Exhibit 38: Chart on Antiemetics - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Antiemetics - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Antiemetics - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Antiemetics - Year-over-year growth 2023-2028 (%); 6.5 Botulinum toxin injection - Market size and forecast 2023-2028; Exhibit 42: Chart on Botulinum toxin injection - Market size and forecast 2023-2028 ($ million); Exhibit 43: Data Table on Botulinum toxin injection - Market size and forecast 2023-2028 ($ million); Exhibit 44: Chart on Botulinum toxin injection - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Botulinum toxin injection - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Drug Class; Exhibit 46: Market opportunity by Drug Class ($ million); Exhibit 47: Data Table on Market opportunity by Drug Class ($ million)
7 Market Segmentation by Disease Type: 7.1 Market segments; Exhibit 48: Chart on Disease Type - Market share 2023-2028 (%); Exhibit 49: Data Table on Disease Type - Market share 2023-2028 (%); 7.2 Comparison by Disease Type; Exhibit 50: Chart on Comparison by Disease Type; Exhibit 51: Data Table on Comparison by Disease Type; 7.3 Idiopathic gastroparesis - Market size and forecast 2023-2028; Exhibit 52: Chart on Idiopathic gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on Idiopathic gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on Idiopathic gastroparesis - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Idiopathic gastroparesis - Year-over-year growth 2023-2028 (%); 7.4 Diabetic gastroparesis - Market size and forecast 2023-2028; Exhibit 56: Chart on Diabetic gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Diabetic gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Diabetic gastroparesis - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Diabetic gastroparesis - Year-over-year growth 2023-2028 (%); 7.5 Post-surgical gastroparesis - Market size and forecast 2023-2028; Exhibit 60: Chart on Post-surgical gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Post-surgical gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Post-surgical gastroparesis - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Post-surgical gastroparesis - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Disease Type; Exhibit 64: Market opportunity by Disease Type ($ million); Exhibit 65: Data Table on Market opportunity by Disease Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share by geography 2023-2028 (%); Exhibit 68: Data Table on Market share by geography 2023-2028 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity by geography; Exhibit 107: Market opportunity by geography ($ million); Exhibit 108: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 Abbott Laboratories; Exhibit 115: Abbott Laboratories - Overview; Exhibit 116: Abbott Laboratories - Business segments; Exhibit 117: Abbott Laboratories - Key news; Exhibit 118: Abbott Laboratories - Key offerings; Exhibit 119: Abbott Laboratories - Segment focus; 12.4 AbbVie Inc.; Exhibit 120: AbbVie Inc. - Overview; Exhibit 121: AbbVie Inc. - Product / Service; Exhibit 122: AbbVie Inc. - Key news; Exhibit 123: AbbVie Inc. - Key offerings; 12.5 ANI Pharmaceuticals Inc.; Exhibit 124: ANI Pharmaceuticals Inc. - Overview; Exhibit 125: ANI Pharmaceuticals Inc. - Product / Service; Exhibit 126: ANI Pharmaceuticals Inc. - Key offerings; 12.6 Bausch Health Companies Inc.; Exhibit 127: Bausch Health Companies Inc. - Overview; Exhibit 128: Bausch Health Companies Inc. - Business segments; Exhibit 129: Bausch Health Companies Inc. - Key news; Exhibit 130: Bausch Health Companies Inc. - Key offerings; Exhibit 131: Bausch Health Companies Inc. - Segment focus; 12.7 Cadila Pharmaceuticals Ltd.; Exhibit 132: Cadila Pharmaceuticals Ltd. - Overview; Exhibit 133: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibit 134: Cadila Pharmaceuticals Ltd. - Key offerings; 12.8 Eisai Co. Ltd.; Exhibit 135: Eisai Co. Ltd. - Overview; Exhibit 136: Eisai Co. Ltd. - Business segments; Exhibit 137: Eisai Co. Ltd. - Key offerings; Exhibit 138: Eisai Co. Ltd. - Segment focus; 12.9 Evoke Pharma Inc.; Exhibit 139: Evoke Pharma Inc. - Overview; Exhibit 140: Evoke Pharma Inc. - Product / Service; Exhibit 141: Evoke Pharma Inc. - Key offerings; 12.10 GlaxoSmithKline Plc; Exhibit 142: GlaxoSmithKline Plc - Overview; Exhibit 143: GlaxoSmithKline Plc - Business segments; Exhibit 144: GlaxoSmithKline Plc - Key news; Exhibit 145: GlaxoSmithKline Plc - Key offerings; Exhibit 146: GlaxoSmithKline Plc - Segment focus; 12.11 Ipca Laboratories Ltd.; Exhibit 147: Ipca Laboratories Ltd. - Overview; Exhibit 148: Ipca Laboratories Ltd. - Product / Service; Exhibit 149: Ipca Laboratories Ltd. - Key offerings; 12.12 Medtronic Plc; Exhibit 150: Medtronic Plc - Overview; Exhibit 151: Medtronic Plc - Business segments; Exhibit 152: Medtronic Plc - Key news; Exhibit 153: Medtronic Plc - Key offerings; Exhibit 154: Medtronic Plc - Segment focus; 12.13 Otsuka Pharmaceutical Co. Ltd.; Exhibit 155: Otsuka Pharmaceutical Co. Ltd. - Overview; Exhibit 156: Otsuka Pharmaceutical Co. Ltd. - Product / Service; Exhibit 157: Otsuka Pharmaceutical Co. Ltd. - Key offerings; 12.14 Pfizer Inc.; Exhibit 158: Pfizer Inc. - Overview; Exhibit 159: Pfizer Inc. - Product / Service; Exhibit 160: Pfizer Inc. - Key news; Exhibit 161: Pfizer Inc. - Key offerings; 12.15 Processa Pharmaceuticals Inc.; Exhibit 162: Processa Pharmaceuticals Inc. - Overview; Exhibit 163: Processa Pharmaceuticals Inc. - Product / Service; Exhibit 164: Processa Pharmaceuticals Inc. - Key offerings; 12.16 Takeda Pharmaceutical Co. Ltd.; Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key offerings; 12.17 Vanda Pharmaceuticals Inc.; Exhibit 169: Vanda Pharmaceuticals Inc. - Overview; Exhibit 170: Vanda Pharmaceuticals Inc. - Product / Service; Exhibit 171: Vanda Pharmaceuticals Inc. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 172: Inclusions checklist; Exhibit 173: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 174: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 175: Research methodology; Exhibit 176: Validation techniques employed for market sizing; Exhibit 177: Information sources; 13.5 List of abbreviations; Exhibit 178: List of abbreviations; Exhibits:; Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class; Exhibits6: Executive Summary - Chart on Market Segmentation by Disease Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global gastroparesis drugs market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Drug Class - Market share 2023-2028 (%); Exhibits31: Data Table on Drug Class - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Drug Class; Exhibits33: Data Table on Comparison by Drug Class; Exhibits34: Chart on Prokinetic agents - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Prokinetic agents - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Prokinetic agents - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Prokinetic agents - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Antiemetics - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Antiemetics - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Antiemetics - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Antiemetics - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Botulinum toxin injection - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Botulinum toxin injection - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Botulinum toxin injection - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Botulinum toxin injection - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Drug Class ($ million); Exhibits47: Data Table on Market opportunity by Drug Class ($ million); Exhibits48: Chart on Disease Type - Market share 2023-2028 (%); Exhibits49: Data Table on Disease Type - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Disease Type; Exhibits51: Data Table on Comparison by Disease Type; Exhibits52: Chart on Idiopathic gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Idiopathic gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Idiopathic gastroparesis - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Idiopathic gastroparesis - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Diabetic gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Diabetic gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Diabetic gastroparesis - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Diabetic gastroparesis - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Post-surgical gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Post-surgical gastroparesis - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Post-surgical gastroparesis - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Post-surgical gastroparesis - Year-over-year growth 2023-2028 (%); Exhibits64: Market opportunity by Disease Type ($ million); Exhibits65: Data Table on Market opportunity by Disease Type ($ million); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share by geography 2023-2028 (%); Exhibits68: Data Table on Market share by geography 2023-2028 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits107: Market opportunity by geography ($ million); Exhibits108: Data Tables on Market opportunity by geography ($ million); Exhibits109: Impact of drivers and challenges in 2023 and 2028; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: Abbott Laboratories - Overview; Exhibits116: Abbott Laboratories - Business segments; Exhibits117: Abbott Laboratories - Key news; Exhibits118: Abbott Laboratories - Key offerings; Exhibits119: Abbott Laboratories - Segment focus; Exhibits120: AbbVie Inc. - Overview; Exhibits121: AbbVie Inc. - Product / Service; Exhibits122: AbbVie Inc. - Key news; Exhibits123: AbbVie Inc. - Key offerings; Exhibits124: ANI Pharmaceuticals Inc. - Overview; Exhibits125: ANI Pharmaceuticals Inc. - Product / Service; Exhibits126: ANI Pharmaceuticals Inc. - Key offerings; Exhibits127: Bausch Health Companies Inc. - Overview; Exhibits128: Bausch Health Companies Inc. - Business segments; Exhibits129: Bausch Health Companies Inc. - Key news; Exhibits130: Bausch Health Companies Inc. - Key offerings; Exhibits131: Bausch Health Companies Inc. - Segment focus; Exhibits132: Cadila Pharmaceuticals Ltd. - Overview; Exhibits133: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibits134: Cadila Pharmaceuticals Ltd. - Key offerings; Exhibits135: Eisai Co. Ltd. - Overview; Exhibits136: Eisai Co. Ltd. - Business segments; Exhibits137: Eisai Co. Ltd. - Key offerings; Exhibits138: Eisai Co. Ltd. - Segment focus; Exhibits139: Evoke Pharma Inc. - Overview; Exhibits140: Evoke Pharma Inc. - Product / Service; Exhibits141: Evoke Pharma Inc. - Key offerings; Exhibits142: GlaxoSmithKline Plc - Overview; Exhibits143: GlaxoSmithKline Plc - Business segments; Exhibits144: GlaxoSmithKline Plc - Key news; Exhibits145: GlaxoSmithKline Plc - Key offerings; Exhibits146: GlaxoSmithKline Plc - Segment focus; Exhibits147: Ipca Laboratories Ltd. - Overview; Exhibits148: Ipca Laboratories Ltd. - Product / Service; Exhibits149: Ipca Laboratories Ltd. - Key offerings; Exhibits150: Medtronic Plc - Overview; Exhibits151: Medtronic Plc - Business segments; Exhibits152: Medtronic Plc - Key news; Exhibits153: Medtronic Plc - Key offerings; Exhibits154: Medtronic Plc - Segment focus; Exhibits155: Otsuka Pharmaceutical Co. Ltd. - Overview; Exhibits156: Otsuka Pharmaceutical Co. Ltd. - Product / Service; Exhibits157: Otsuka Pharmaceutical Co. Ltd. - Key offerings; Exhibits158: Pfizer Inc. - Overview; Exhibits159: Pfizer Inc. - Product / Service; Exhibits160: Pfizer Inc. - Key news; Exhibits161: Pfizer Inc. - Key offerings; Exhibits162: Processa Pharmaceuticals Inc. - Overview; Exhibits163: Processa Pharmaceuticals Inc. - Product / Service; Exhibits164: Processa Pharmaceuticals Inc. - Key offerings; Exhibits165: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibits166: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibits167: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibits168: Takeda Pharmaceutical Co. Ltd. - Key offerings; Exhibits169: Vanda Pharmaceuticals Inc. - Overview; Exhibits170: Vanda Pharmaceuticals Inc. - Product / Service; Exhibits171: Vanda Pharmaceuticals Inc. - Key offerings; Exhibits172: Inclusions checklist; Exhibits173: Exclusions checklist; Exhibits174: Currency conversion rates for US$; Exhibits175: Research methodology; Exhibits176: Validation techniques employed for market sizing; Exhibits177: Information sources; Exhibits178: List of abbreviations